| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 28.856 | 117.429 | 97.150 | 78.932 | 133.022 |
| Total Income - EUR | - | - | - | - | - | 28.856 | 117.429 | 97.150 | 78.932 | 133.022 |
| Total Expenses - EUR | - | - | - | - | - | 21.751 | 97.733 | 92.440 | 87.145 | 136.962 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 7.105 | 19.696 | 4.710 | -8.214 | -3.940 |
| Net Profit/Loss - EUR | - | - | - | - | - | 6.270 | 16.596 | 3.855 | -8.900 | -7.104 |
| Employees | - | - | - | - | - | 0 | 1 | 1 | 2 | 2 |
Check the financial reports for the company - Depomedical Pharma S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 0 | 0 | 13.844 | 10.377 |
| Current Assets | - | - | - | - | - | 9.294 | 31.457 | 50.543 | 35.478 | 49.772 |
| Inventories | - | - | - | - | - | 537 | 1.305 | 9.413 | 700 | 1.326 |
| Receivables | - | - | - | - | - | 205 | 967 | 981 | 1.170 | 324 |
| Cash | - | - | - | - | - | 8.552 | 29.185 | 40.149 | 33.608 | 48.122 |
| Shareholders Funds | - | - | - | - | - | 6.312 | 22.768 | 26.693 | 17.712 | 10.509 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 2.982 | 8.690 | 23.849 | 31.716 | 49.831 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Depomedical Pharma S.r.l.